Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series
The novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709620984603 |
_version_ | 1818323249588600832 |
---|---|
author | Shikha G. Khosla MD Eric S. Nylen MD Rahul Khosla MD |
author_facet | Shikha G. Khosla MD Eric S. Nylen MD Rahul Khosla MD |
author_sort | Shikha G. Khosla MD |
collection | DOAJ |
description | The novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intracellular contents into circulation. It is characterized by marked elevations of creatinine kinase levels and myoglobinuria. In this article, we describe a series of 5 cases who were admitted with COVID-19 pneumonia and had severe muscle injury, as demonstrated by significant elevation (>5 times upper limit of normal) of creatinine kinase levels likely secondary to SARS-CoV-2 virus. The median age for these patients was 65 years, and most of them suffered from diabetes and hyperlipidemia. All patients were hypertensive males. Four out of 5 patients had preserved kidney function at baseline and were chronic kidney disease (CKD) stage 2 or better. However, most of them suffered significant kidney injury and at the time of discharge one patient was CKD stage 2 or better, 2 were CKD stage 3 or worse, and 2 patients had renal failure and died due to complications of SARS-CoV-2 infection. |
first_indexed | 2024-12-13T11:09:42Z |
format | Article |
id | doaj.art-9618d8fc5e944a5798ef4e9edb5a89b3 |
institution | Directory Open Access Journal |
issn | 2324-7096 |
language | English |
last_indexed | 2024-12-13T11:09:42Z |
publishDate | 2020-12-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Journal of Investigative Medicine High Impact Case Reports |
spelling | doaj.art-9618d8fc5e944a5798ef4e9edb5a89b32022-12-21T23:48:48ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962020-12-01810.1177/2324709620984603Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case SeriesShikha G. Khosla MD0Eric S. Nylen MD1Rahul Khosla MD2George Washington University, Washington, DC, USAGeorge Washington University, Washington, DC, USAGeorge Washington University, Washington, DC, USAThe novel SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) is now known to cause acute respiratory distress, cytokine storm, and coagulopathy. Multiple other manifestations have been published in recent literature. Rhabdomyolysis is a syndrome of muscle damage, with release of intracellular contents into circulation. It is characterized by marked elevations of creatinine kinase levels and myoglobinuria. In this article, we describe a series of 5 cases who were admitted with COVID-19 pneumonia and had severe muscle injury, as demonstrated by significant elevation (>5 times upper limit of normal) of creatinine kinase levels likely secondary to SARS-CoV-2 virus. The median age for these patients was 65 years, and most of them suffered from diabetes and hyperlipidemia. All patients were hypertensive males. Four out of 5 patients had preserved kidney function at baseline and were chronic kidney disease (CKD) stage 2 or better. However, most of them suffered significant kidney injury and at the time of discharge one patient was CKD stage 2 or better, 2 were CKD stage 3 or worse, and 2 patients had renal failure and died due to complications of SARS-CoV-2 infection.https://doi.org/10.1177/2324709620984603 |
spellingShingle | Shikha G. Khosla MD Eric S. Nylen MD Rahul Khosla MD Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series Journal of Investigative Medicine High Impact Case Reports |
title | Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series |
title_full | Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series |
title_fullStr | Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series |
title_full_unstemmed | Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series |
title_short | Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series |
title_sort | rhabdomyolysis in patients hospitalized with covid 19 infection five case series |
url | https://doi.org/10.1177/2324709620984603 |
work_keys_str_mv | AT shikhagkhoslamd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries AT ericsnylenmd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries AT rahulkhoslamd rhabdomyolysisinpatientshospitalizedwithcovid19infectionfivecaseseries |